samedan logo
 
 
 
spacer
home > ebr > autumn 2020 > how pharma can conquer the next pandemic
PUBLICATIONS
European Biopharmaceutical Review

How Pharma Can Conquer the Next Pandemic

The COVID-19 pandemic has brought a level of global disruption unseen in most of our lifetimes, with countries around the world continuing to grapple with infection rates and lockdown restrictions.

While we’re still some way away from a realistic end to the crisis, we are starting to see some positive developments rising from the gloom: countries in Europe and Asia are seeing their mitigation and suppression efforts starting to bear fruit, and track and trace systems have been implemented and are improving in efficacy by the day. Treatments, and our general understanding of the virus, are also progressing, with dexamethasone emerging as a viable treatment for the sickest patients. Meanwhile, early clinical trials of several different vaccines have had promising results.

Unsurprisingly, the pharmaceutical industry has led the charge in the battle against COVID-19 in many respects, and will continue to be at the forefront of the global response in the months to come. Given the upheaval that the current outbreak has caused, the way the world responds will act as a blueprint for future pandemics. With this in mind, the pharma industry must learn as many valuable lessons from the situation as possible.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Vladimir Tkachenko, a pharmaceutical sciences expert, is General Manager of Amaxa Pharma, a UK-headquartered pharma company focused on life-threatening therapeutic areas such as oncology and neonatology in the Commonwealth of Independent States countries. Within this role, Vladimir is responsible for the general management and success of the company, developing sales strategy, implementing managerial accounting strategy, preparing operation budgets and licensing. Since joining Amaxa Pharma in 2012, Vladimir has been instrumental in its success in Europe, driving effective partnerships and bringing life-changing prescription and non-prescription medicines for the treatment of patients suffering from cancer, blood-related diseases, premature birth, and other life-threatening illnesses.
spacer
Vladimir Tkachenko
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Bilim Pharmaceuticals, H&T Presspart and Hovione Technology unveil collaboration for new asthma product: Ventofor Combi Fix delivered by PowdAir Plus

1st September 2020 – Bilim Pharmaceuticals, a Turkish company manufacturing and marketing pharmaceutical drugs, H&T Presspart, a global provider of respiratory drug-delivery devices and components to the pharmaceutical sector, and Hovione Technology, a pharmaceutical specialist in the development of innovative pulmonary device technology, today unveiled a collaboration supporting Bilim Pharmaceutical’s launch into the Turkish market of Ventofor Combi Fix, a formulation of Budesonide Formoterol for Asthma and COPD management, delivered by the PowdAir Plus Dry Powder Inhaler (DPI).
More info >>

White Papers

Stripping the confusion out of PVC curtains... and a new seat range.

Teknomek Ltd

With the ever-growing trend towards modularisation of clean rooms and laboratories; Teknomek have responded with a new range of PVC strip curtains, suitable for use in environments where maintaining clean airflow is critical. This new PVC curtain range includes specialist perforated and electrostatic discharge alternatives to the standard options of clear and polar (-25oC) versions.
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement